Loading companies…
United Kingdom · Healthtech · AI
Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.
Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.
Its olfactory chip is designed to detect multiple volatile organic compounds in parallel. The current work targets biomarker screening in urine, sweat and other bodily fluids; the company describes the technology as being in development.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-seed | £700K | SFC Capital — LeadZinc — LeadInnovate UK — Participant |